Transduction of cancer cells with herpes simplex virus thy-HSVtk-transduced tumor cells after the cell cycle arrest midine kinase gene (HSVtk) followed by prodrug gancicloand before apoptosis. Increased expression of FasL could vir (GCV) treatment has been shown to induce apoptosis. also be observed in vivo in HSVtk-transduced tumors In this study, four murine tumors including B16F10 melainduced to regress by GCV treatment. Enzyme measurenoma, NG4TL4 sarcoma, H6 hepatoma and 1MEA 7R.1 ments using specific substrate showed that the caspase-3 hepatoma were found to vary in sensitivity to this gene activation followed kinetically the FasL expression. More therapy strategy in vitro but, at effective doses of GCV, the than half of the HSVtk/GCV-induced cell death could be HSVtk-transduced cells of all four tumors showed similar abrogated by addition to the cell culture medium of a spekinetics of early rise in p53 protein levels, then cell cycle cific antisense oligonucleotide to block FasL synthesis, a S-/G2-phase arrest and finally signs of apoptosis. Immunorecombinant Fas/Fc chimeric protein to compete with Fas blot analyses revealed that Fas (CD95/APO-1), Fas ligand receptor for FasL binding, or cell-permeable specific tetra-(FasL) and two downstream mediators, RIP and caspase-3 peptide inhibitors of caspase-3 or caspase-8. (CPP32, YAMA, Apopain) were increased in GCV-treated